Medical StudentPeking University First HospitalBeijing, Beijing, China (People's Republic)
Disclosure information not submitted.
SUN-279 - Immune Checkpoint Inhibitor Administration after 11:30 AM Reduces Endocrine Immune-Related Adverse Events in Tyrosine Kinase Inhibitor Combination Therapy
Sunday, June 14, 20269:00 AM - 4:00 PM CT